ATTENUATED MYCOPLASMA GALLISEPTICUM STRAIN, VACCINE COMPOSITION AND VACCINATION METHOD Russian patent published in 2012 - IPC C12N1/20 A61K39/02 G01N33/569 

Abstract RU 2441909 C2

FIELD: immunology.

SUBSTANCE: invention refers to the area of microbiology and immunology and provides attenuated Mycoplasma gallisepticum bacteria, vaccine composition as well as methods of vaccinating an animal, which strain was deposited with the American Type Culture Collection (FNCC) and has been assigned Accession No. PTA-8485.

EFFECT: reduced expression of protein, identified as MGA_0621, which was shown to exhibit significantly reduced expression of MGA_0621, and was shown to be safe and effective when administered as a vaccine against M. gallisepticum infection.

4 cl, 1 dwg, 5 tbl, 3 ex

Similar patents RU2441909C2

Title Year Author Number
LIVE ATTENUATED MYCOPLASMA BACTERIUM, VACCINE CONTAINING IT AND METHOD FOR IDENTIFYING SUCH BACTERIUM 2008
  • Kumar Makhesh
  • Khan Mukhammad Ajub
RU2473682C2
LIVE ATTENUATED VACCINES 2010
  • Brauning, Glenn Frehnsis
  • Markkhehm, Fillip Frehnsis
  • Tseng, Chi-Ven
RU2556813C2
LIVE ATTENUATED Pasteurella multocida BACTERIUM, BASED VACCINE, METHOD FOR MAKING VACCINE AND USING SUCH BACTERIUM FOR MAKING VACCINE FOR ANIMAL OR HUMAN PROTECTION 2005
  • Lo Jujgan
  • Vermehj Paul'
  • Jakobs Antonius Arnol'Dus Kristian
RU2415926C2
RECOMBINANT ATTENUATED MICROORGANISMS CLOSTRIDIUM AND VACCINE 2007
  • Kokrehn Mark D.
  • Petersen Gehri
  • Lehjr Stiven V.
  • Sinenki Richard
RU2445364C2
MINUS-CHAIN-CONTAINING ATTENUATED VIRUSES WITH CHANGED ANTAGONISTIC ACTIVITY AS REGARDS FOR INTERFERON FOR APPLYING AS VACCINES AND PHARMACEUTICAL SUBSTANCES 1999
  • Palez Piter
  • Garsia-Sastre Adol'Fo
  • Master Tomas
RU2236252C2
DUCK ENTERITIS VIRUS AND USE THEREOF 2016
  • Yukari, Saeki
  • Saitoh, Shuji
RU2721575C2
MUTANT MYCOPLASMA HYOPNEUMONIAE STRAINS 2013
  • Gonsales Gonsales Luis
  • Pinol Ribas Khaume
  • Montane Khiralt Khordi
  • Kamats Malet Mariya
  • Kerol Murilo Enrike
  • Sitkha Arnau Marta
RU2689671C2
RECOMBINANT MAREK'S DISEASE VIRUSES AND USES THEREOF 2014
  • Esaki Motoyuki
  • Saito Sudzi
  • Sato Takanori
RU2681889C2
ESSENTIALLY NON-TOXIC MUTEIN OF Clostridium perfringens ALPHA TOXIN AND NUCLEIC ACID MOLECULE CODING SAME 2007
  • Kokren Mark D.
  • Petersen Geri
  • Lejr Stiven V.
  • Sinenki Richard
RU2593945C2
VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE 2018
  • Witvliet, Maarten, Hendrik
  • Van Den Born, Erwin
  • Sno, Melanie
  • Jacobs, Antonius, Arnoldus, Christiaan
RU2756767C2

RU 2 441 909 C2

Authors

Kumar Makhesh

Khan Mukhammad Ajub

Dates

2012-02-10Published

2008-09-10Filed